You searched for "OCTA"

692 results found

The Worshipful Company of Spectacle Makers rewards early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...

Macular holes: A brief review

The classification of macular holes has been modernised by OCT findings. This is a brief review and encompasses the historical literature on macular holes. A macular hole is an anatomical discontinuation of the neurosensory retina at the centre of the...

World Clinics in Ophthalmology Series: Innovations in Primary Open Angle Glaucoma

This two volume publication about current innovations in primary open angle glaucoma has persevered to come out with a comprehensive review of the latest publications in the world of glaucoma. The list of contributors includes clinicians from the field of...

Intravitreal afibercept and ranibizumab for PCV

This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...

AI can identify treatment gaps for patients with macular disease, study shows

Using artificial intelligence (AI) in eye clinics could reduce both undertreatment and overtreatment of neovascular or ‘wet’ age-related macular degeneration (AMD). AMD is the leading cause of irreversible vision loss in older people and accounts for around 1 in 10...

Two cases of acute syphilitic posterior placoid chorioretinitis

Syphilis has re-emerged as a significant public health concern, with the World Health Organization (WHO) estimating that 8 million adults aged 15–49 acquired syphilis in 2022. Untreated syphilis can have severe consequences, including cardiovascular, neurological and ocular complications. Ocular manifestations...

The science of glaucoma management: highlights of the 2020 Moorfields International Glaucoma Symposium

Held earlier this year, the 12th annual Moorfields International Glaucoma Symposium provided a forum for advanced clinical and scientific exchange in glaucoma management. The authors describe the key presentation themes and debates, highlighting specific topics of interest to glaucoma specialists....

Glaucoma UK announces £100,000 Health and Social Care Professionals Award for 2024

Glaucoma UK is pleased to announce that applications for its Health and Social Care Professionals Research Award are now open.

Moorfields: Joint Ocular Oncology and Vitreo Retinal Symposium for Nurses and Ophthalmic Health Care Professionals

Following the success in 2024 of our first Joint Ocular Oncology and Vitreo Retinal Symposium for Nurses and Ophthalmic Health Care Professionals, we are delighted to announce that the symposium will take place again on 15 November 2025. This unique...

Dramatic myopic shift due to epithelial basement membrane dystrophy

Epithelial basement membrane dystrophy (EBMD), also known as map-dot-fingerprint dystrophy, is a common anterior corneal disorder affecting approximately 2% of the population [1]. It is characterised by the abnormal maintenance of the basement membrane, resulting in protrusions into the epithelium....

Transferring imaging from primary to secondary care (part 1)

Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. For...

Sclerochoroidal calcification masquerading as ocular malignancy

Case 1 A 68-year-old Caucasian gentleman was urgently referred to eye casualty by his optometrist after seeing an unusual incidental finding of protruding lesions from the retina, suspecting choroidal melanoma. He was asymptomatic and this was his first eye test...